To Describe the Use of Intravitreal Aflibercept and to Describe Follow-up as Well as Treatment Patterns in Patients With Wet Age-related Macular Degeneration (wAMD) or Diabetic Macular Edema (DME) in Routine Clinical Practice in Canada.
Clinical trial NCT02540369 · COMPLETED
Trial details
- NCT number
- NCT02540369
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-12-14
- Primary completion
- 2017-09-25
- Enrollment
- 2150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.